The U.S. Food and Drug Administration has cleared the Signos Glucose Monitoring System, an over-the-counter glucose mo ...

The FDA cleared the first glucose monitoring system specifically designed for weight management from Signos, providing a new ...

The FDA approved the first over-the-counter glucose monitoring system designed to help with weight management. Developed by health technology company Signos, the system combines the Stelo by Dexcom ...

FDA approves glucose weight loss monitoring app. Aside from dieting, there are alternatives to losing weight. This includes ...

Signos Inc. landed U.S. FDA clearance for its over-the-counter glucose monitoring system, which combines Dexcom Inc.'s ...

The Signos Glucose Monitoring System is a mobile device application that receives data from an OTC integrated continuous ...

财联社8月20日讯（编辑 赵昊）美国食品药品监督管理局（FDA）周三（8月20日）批准了由美国初创公司Signos推出的首个专门用于减重的血糖监测系统，这为美国人提供了一种全新的体重管理选择。

The system, from Signos, offers three- and six-month plans ($139 and $129 a month, respectively), and the company will send all of the continuous glucose monitors a patient needs, CNBC reported. Plus: ...

The FDA has approved Sisnos’s continuous glucose monitoring (CGM) system for consumer use beyond diabetes management, ...

Palo Alto, California-based Signos integrated the Dexcom Stelo OTC continuous glucose monitor (CGM) with an AI-powered ...

Any patient can access Signos' system, which uses an AI platform and an off-the-shelf continuous glucose monitor, or CGM, ...

Orforglipron, the new weight loss pill manufactured by Eli Lilly, helped patients in a recent study lose a significant amount of weight, the company said.